J. K. Blusztajn

Sequence of Deposition of Heterogeneous Amyloid β-Peptides and APO E in Down Syndrome: Implications for Initial Events in Amyloid Plaque Formation

Cynthia A. Lemere, J. K. Blusztajn, H Yamaguchi et al. · Neurobiology of Disease · 1996 · 593 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Synthesis of acetylcholine from choline derived from phosphatidylcholine in a human neuronal cell line.

J. K. Blusztajn, Mordechai Liscovitch, U. Ingrid Richardson · Proceedings of the National Academy of Sciences · 1987 · 150 citations · Full text

Life Sciences, Neurobiology, Neuroscience +13

Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3

Ulrike Schueler, Thomas Kolter, Christine R. Kaneski et al. · Neurobiology of Disease · 2003 · 98 citations · Full text

Life Sciences, Neurobiology, Neuroscience +11

Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients

J. K. Blusztajn, Ignacio Lopez Gonzalez-Coviella, M. Logue et al. · Brain Research · 1990 · 97 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Phospholipase D-catalyzed hydrolysis of phosphatidylcholine provides the choline precursor for acetylcholine synthesis in a human neuronal cell line.

H C Lee, M P Fellenz-Maloney, Mordechai Liscovitch et al. · Proceedings of the National Academy of Sciences · 1993 · 77 citations

Life Sciences, Biochemistry, Neuroscience +16